Partnerships for a healthier world at WEF
By Tara Newton, Senior Communications Associate, BID Initiative
Jan 24, 2017
The World Economic Forum (WEF) Annual Meeting in Davos last week brought together the foremost political, business and society leaders together to shape global, regional, and industry agendas. The event offered a platform for leaders to share insights and innovations on how to best navigate the future.
PATH President and CEO, Steve Davis, attended the forum and shared his thoughts on the business model for saving the world –
“The secret is working together to design solutions specifically for low-resource settings—and then delivering them at scale.”
Several cross-sector partnerships and initiatives were launched at the WEF annual meeting that aim to transform health and save more lives.
A coalition to get ahead of pandemics
The Coalition for Epidemic Preparedness Innovations (CEPI) pursues a proactive and accelerated vaccine development strategy for epidemic threats by supporting innovative medical technologies. Conceived in response to the recent Ebola and Zika outbreaks, CEPI is targeting MERS-CoV, Lassa and Nipah to start since they all have serious potential to cause epidemics. The hope is that when an outbreak happens, the vaccines will be ready. Initial funding of $460 million has been provided by the Bill & Melinda Gates Foundation, the Wellcome Trust, and the governments of Germany, Japan, and Norway.
A cross-sector partnership to improve delivery of lifesaving vaccines
Deutsche Post DHL Group, the leading global mail and logistics company, and Gavi, the Vaccine Alliance, are partnering to help provide countries with efficient supply chain solutions to improve healthcare delivery. Kenya, in partnership with their Ministry of Health, will be the first country to test the transportation management solution incorporating a control tower to better manage and coordinate third-party transport carriers and the use of DHL’s own global transportation network.
Drug makers in Davos shift focus to chronic diseases of the poor
Twenty-two global pharmaceutical companies announced an investment of $50 million over three years to fight cancer and other non-communicable diseases (NCDs) as part of the Access Accelerated Initiative backed by the World Bank. Aiming to improve both treatment and prevention of NCD’s such as cancer, diabetes, and heart and lung disorders; the initiative will also focus on improved health care systems in developing countries to accommodate advanced medicine.
Partnering to meet the sustainable development goals for women, children and adolescent health
Merck & Co. announced a $10 million commitment to the Global Financing Facility (GFF) in support of Every Woman Every Child to improve maternal and child health in low- and lower-middle-income countries worldwide through its MSD for Mothers initiative. The contribution will scale up high impact interventions to help women and children to survive and thrive through birth, the early years, and adolescence.
These partnerships and innovative approaches for a healthier world are just a few announced at the annual meeting. At the BID Initiative, we rely heavily on partners such as our BLN members, other implementing organizations, country governments, software companies, and more to bring our vision of better data and decision making for better health to life. We are encouraged by the collaboration and as Steve Davis said, “it is key to bringing innovative solutions to scale.”